PARP7 inhibitors combined with RDC and their use in cancer treatment

TW202637164APending Publication Date: 2026-09-16KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115102799
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2026-01-20
Filing Date
2026-01-23
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001077101_001
    Figure TWG2TA001077101_001
  • Figure TWG2TA001077101_002
    Figure TWG2TA001077101_002
  • Figure TWG2TA001077101_003
    Figure TWG2TA001077101_003
Patent Text Reader

Abstract

This application relates to a combination of PARP7 inhibitors and RDCs and their use in the treatment of tumors.
Need to check novelty before this filing date? Find Prior Art